BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23948707)

  • 21. Activation of TRPC6 calcium channels by diacylglycerol (DAG)-containing arachidonic acid: a comparative study with DAG-containing docosahexaenoic acid.
    Aires V; Hichami A; Boulay G; Khan NA
    Biochimie; 2007 Aug; 89(8):926-37. PubMed ID: 17532549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental changes in the expression and function of TRPC6 channels related the F-actin organization during differentiation in podocytes.
    Liu Z; Yang J; Zhang X; Xu P; Zhang T; Yang Z
    Cell Calcium; 2015 Dec; 58(6):541-8. PubMed ID: 26363733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms.
    Fan Q; Zhang H; Ding J; Liu S; Miao J; Xing Y; Yu Z; Guan N
    Genes Cells; 2009 Sep; 14(9):1079-90. PubMed ID: 19674119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
    Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
    Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice.
    Weissmann N; Sydykov A; Kalwa H; Storch U; Fuchs B; Mederos y Schnitzler M; Brandes RP; Grimminger F; Meissner M; Freichel M; Offermanns S; Veit F; Pak O; Krause KH; Schermuly RT; Brewer AC; Schmidt HH; Seeger W; Shah AM; Gudermann T; Ghofrani HA; Dietrich A
    Nat Commun; 2012 Jan; 3():649. PubMed ID: 22337127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic signaling evoked by tumor necrosis factor in podocytes.
    Abkhezr M; Kim EY; Roshanravan H; Nikolos F; Thomas C; Hagmann H; Benzing T; Dryer SE
    Am J Physiol Renal Physiol; 2015 Jul; 309(2):F98-108. PubMed ID: 26017975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High glucose modifies transient receptor potential canonical type 6 channels via increased oxidative stress and syndecan-4 in human podocytes.
    Thilo F; Lee M; Xia S; Zakrzewicz A; Tepel M
    Biochem Biophys Res Commun; 2014 Jul; 450(1):312-7. PubMed ID: 24942878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice.
    Oda S; Numaga-Tomita T; Kitajima N; Toyama T; Harada E; Shimauchi T; Nishimura A; Ishikawa T; Kumagai Y; Birnbaumer L; Nishida M
    Sci Rep; 2017 Aug; 7(1):7511. PubMed ID: 28790356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
    Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
    Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diacylglycerol analogues activate second messenger-operated calcium channels exhibiting TRPC-like properties in cortical neurons.
    Tu P; Kunert-Keil C; Lucke S; Brinkmeier H; Bouron A
    J Neurochem; 2009 Jan; 108(1):126-38. PubMed ID: 19094061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species.
    Liu BC; Song X; Lu XY; Li DT; Eaton DC; Shen BZ; Li XQ; Ma HP
    Biochim Biophys Acta; 2013 Jun; 1833(6):1434-42. PubMed ID: 23499875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human TRPC6 expressed in HEK 293 cells forms non-selective cation channels with limited Ca2+ permeability.
    Estacion M; Sinkins WG; Jones SW; Applegate MA; Schilling WP
    J Physiol; 2006 Apr; 572(Pt 2):359-77. PubMed ID: 16439426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6.
    Fuchs B; Rupp M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Gudermann T; Dietrich A; Weissmann N
    Respir Res; 2011 Feb; 12(1):20. PubMed ID: 21294865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.
    Hall G; Rowell J; Farinelli F; Gbadegesin RA; Lavin P; Wu G; Homstad A; Malone A; Lindsey T; Jiang R; Spurney R; Tomaselli GF; Kass DA; Winn MP
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1442-50. PubMed ID: 24740790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.
    Zhang C; Xia M; Boini KM; Li CX; Abais JM; Li XX; Laperle LA; Li PL
    Pflugers Arch; 2011 Sep; 462(3):455-67. PubMed ID: 21647593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation.
    Jiang L; Ding J; Tsai H; Li L; Feng Q; Miao J; Fan Q
    Exp Biol Med (Maywood); 2011 Feb; 236(2):184-93. PubMed ID: 21321315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.
    Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL
    Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling.
    Chen L; Tang YL; Liu ZH; Pan Y; Jiao RQ; Kong LD
    Eur J Pharmacol; 2021 Dec; 913():174616. PubMed ID: 34780752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.